Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder
22q11.2 deletion syndrome (22q11DS) is a risk factor for psychiatric illnesses, including schizophrenia and anxiety. Small studies have shown that several neuroleptic medications are effective in treating psychosis in this population, but are also associated with an increased risk of adverse effects...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-10-01
|
| Series: | Mental Illness |
| Subjects: | |
| Online Access: | http://www.pagepress.org/journals/index.php/mi/article/view/7225 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | 22q11.2 deletion syndrome (22q11DS) is a risk factor for psychiatric illnesses, including schizophrenia and anxiety. Small studies have shown that several neuroleptic medications are effective in treating psychosis in this population, but are also associated with an increased risk of adverse effects - particularly, seizures. In this case, we discuss a 34-year-old patient presenting with late onset schizophrenia, which ultimately led to her diagnosis of 22q11DS. Subsequent management of the patient’s psychosis with asenapine was complicated by concurrent anxiety and panic disorder; thus, we examine the role of anxiolytic therapy in conjunction with antipsychotics in this patient population. |
|---|---|
| ISSN: | 2036-7457 2036-7465 |